Related Experiment Video
Updated: Jan 8, 2026

08:31
Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
Published on: September 12, 2025
732
Three practice updates in non-Hodgkin lymphoma for 2026
Rebecca L King1, Sarah J Ondrejka2, James R Cook2
1Division of Hematopathology, Mayo Clinic, Rochester, MN, USA.
Human Pathology
|December 13, 2025
Summary
Navigating lymphoid neoplasms requires distinguishing between various non-Hodgkin lymphomas using morphology and ancillary studies. This review updates classifications for follicular lymphoma, high-grade B-cell lymphomas, and nodal T-cell lymphomas.
Area of Science:
- Hematology
- Pathology
- Oncology
Background:
- Lymphoid neoplasms pose diagnostic challenges in surgical pathology.
- Distinguishing non-Hodgkin lymphoma subtypes requires morphology and ancillary studies.
- Current practice uses both the World Health Organization (5th ed.) and International Consensus Classification systems.
Purpose of the Study:
- Provide practical updates on classifying challenging lymphoid neoplasms.
- Offer guidance on follicular lymphoma, high-grade B-cell lymphomas, and nodal T-cell lymphomas.
- Advise on ancillary studies and navigating current classification systems.
Main Methods:
- Review of current literature and classification systems.
- Focus on morphologic evaluation and ancillary studies (immunohistochemistry, flow cytometry, NGS).
- Comparative analysis of classification approaches for specific lymphoma types.
Main Results:
- Detailed evaluation strategies for follicular lymphoma subtypes.
- Current approaches to high-grade B-cell lymphomas, including double-hit and NOS variants.
- Features of common nodal T-cell lymphomas (T-follicular helper, anaplastic large cell, PTCL-NOS).
Conclusions:
- Accurate classification of lymphoid neoplasms is crucial for patient management.
- Understanding differences between classification systems aids diagnostic accuracy.
- Ancillary studies are essential for definitive diagnosis and subtyping.
Related Concept Videos
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Primary Lymphoid Organs
14.5K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
14.5K
Secondary Lymphoid Organs
8.7K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
8.7K

